BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26414087)

  • 1. Societal costs of diabetes mellitus in Denmark.
    Sortsø C; Green A; Jensen PB; Emneus M
    Diabet Med; 2016 Jul; 33(7):877-85. PubMed ID: 26414087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term societal economic burden of first-incident type 2 diabetes-related complications - a nationwide cohort study.
    Kjellberg J; Tikkanen CK; Bagger M; Gæde P
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):577-586. PubMed ID: 33054434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of illness of atrial fibrillation: a nationwide study of societal impact.
    Johnsen SP; Dalby LW; Täckström T; Olsen J; Fraschke A
    BMC Health Serv Res; 2017 Nov; 17(1):714. PubMed ID: 29126415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Costs Attributable to Diabetes in Each U.S. State.
    Shrestha SS; Honeycutt AA; Yang W; Zhang P; Khavjou OA; Poehler DC; Neuwahl SJ; Hoerger TJ
    Diabetes Care; 2018 Dec; 41(12):2526-2534. PubMed ID: 30305349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
    Salman RA; AlSayyad AS; Ludwig C
    BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attributable societal costs of first-incident obesity-related cardiovascular comorbidities in Denmark.
    Kjellberg J; Tikkanen CK
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):673-681. PubMed ID: 33794723
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.
    Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž
    Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
    Sortsø C; Komkova A; Sandbæk A; Griffin SJ; Emneus M; Lauritzen T; Simmons RK
    Diabetologia; 2018 Jun; 61(6):1306-1314. PubMed ID: 29549417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
    Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
    Gundgaard J; Christensen TE; Thomsen TL
    Prim Care Diabetes; 2010 Oct; 4(3):165-72. PubMed ID: 20452847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2.
    Soerensen AV; Donskov F; Kjellberg J; Ibsen R; Hermann GG; Jensen NV; Fode K; Geertsen PF
    Eur Urol; 2015 Sep; 68(3):516-22. PubMed ID: 25533417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
    Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
    PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
    Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R
    World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
    Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
    Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
    [No Abstract]   [Full Text] [Related]  

  • 20. Overweight and obesity on the island of Ireland: an estimation of costs.
    Dee A; Callinan A; Doherty E; O'Neill C; McVeigh T; Sweeney MR; Staines A; Kearns K; Fitzgerald S; Sharp L; Kee F; Hughes J; Balanda K; Perry IJ
    BMJ Open; 2015 Mar; 5(3):e006189. PubMed ID: 25776042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.